Palomar Holdings, Inc. (NASDAQ:PLMR) Receives $158.14 Average PT from Brokerages

Shares of Palomar Holdings, Inc. (NASDAQ:PLMR) have received an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $158.1429.

PLMR has been the topic of several recent analyst reports. Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Wall Street Zen lowered shares of Palomar from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. JPMorgan Chase & Co. upped their target price on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Evercore ISI began coverage on Palomar in a research report on Monday, February 9th. They set an “outperform” rating and a $150.00 price target on the stock. Finally, Keefe, Bruyette & Woods upped their target price on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 6th.

Palomar Price Performance

Shares of PLMR opened at $132.10 on Friday. Palomar has a fifty-two week low of $107.75 and a fifty-two week high of $175.85. The company has a market capitalization of $3.50 billion, a price-to-earnings ratio of 18.40 and a beta of 0.44. The business’s 50-day moving average is $128.74 and its 200-day moving average is $123.14.

Palomar (NASDAQ:PLMR) last issued its earnings results on Wednesday, February 11th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.06 by $0.18. The company had revenue of $492.63 million for the quarter, compared to analyst estimates of $204.58 million. Palomar had a return on equity of 22.77% and a net margin of 22.50%.The business’s revenue was up 62.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.52 EPS. Equities research analysts expect that Palomar will post 5.99 earnings per share for the current fiscal year.

Palomar News Summary

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Q4 earnings and revenue beat consensus, driven by higher premiums and underwriting gains; management also raised its 2026 outlook — a primary driver of the stock’s strength. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
• Positive Sentiment: Brokerage coverage remains constructive — the consensus recommendation is around “Moderate Buy,” which supports continued investor interest. Palomar Given Average Recommendation of “Moderate Buy” by Brokerages
• Neutral Sentiment: Analyst/press deep-dive notes that Palomar’s diversification is driving top-line growth, but highlights emerging questions about margins and underwriting mix — watch margin trends in upcoming quarters. PLMR Q4 deep dive: Diversification drives growth, margin questions emerge
• Neutral Sentiment: Full Q4 earnings call transcript is available for detail on management’s commentary and guidance assumptions — useful for investors modeling forward earnings and loss ratios. Palomar Q4 2025 Earnings Call Transcript
• Negative Sentiment: Insider sale: CEO Mac Armstrong sold 5,000 shares at ~$122.60 (filed with the SEC), trimming his stake by ~1.44% — a potential sentiment headwind even though his remaining holding remains large. SEC Filing: Insider Sale

Insider Activity

In other news, CEO Mac Armstrong sold 11,484 shares of Palomar stock in a transaction that occurred on Wednesday, January 28th. The stock was sold at an average price of $119.88, for a total transaction of $1,376,701.92. Following the completion of the transaction, the chief executive officer directly owned 91,737 shares in the company, valued at approximately $10,997,431.56. The trade was a 11.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO T Christopher Uchida sold 2,103 shares of the stock in a transaction on Wednesday, January 28th. The stock was sold at an average price of $119.88, for a total value of $252,107.64. Following the transaction, the chief financial officer owned 11,473 shares in the company, valued at $1,375,383.24. The trade was a 15.49% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 63,998 shares of company stock worth $7,868,669 over the last 90 days. 3.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Palomar

Several institutional investors have recently made changes to their positions in the stock. Principal Financial Group Inc. boosted its stake in shares of Palomar by 14.0% during the third quarter. Principal Financial Group Inc. now owns 182,255 shares of the company’s stock valued at $21,278,000 after purchasing an additional 22,346 shares in the last quarter. Osaic Holdings Inc. raised its holdings in Palomar by 93.7% in the 2nd quarter. Osaic Holdings Inc. now owns 19,370 shares of the company’s stock valued at $2,933,000 after buying an additional 9,371 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Palomar in the 3rd quarter valued at approximately $1,459,000. Sumitomo Mitsui Trust Group Inc. boosted its position in Palomar by 11.1% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 456,172 shares of the company’s stock worth $53,258,000 after buying an additional 45,665 shares during the period. Finally, Bessemer Group Inc. increased its position in Palomar by 41.1% in the 3rd quarter. Bessemer Group Inc. now owns 153,683 shares of the company’s stock valued at $17,943,000 after acquiring an additional 44,745 shares during the period. 90.25% of the stock is currently owned by institutional investors.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.